NCT02099240 arm group 13c5cdeba4326b6781e2f783c9fb988f [clinicaltrials_resource:NCT02099240/arm-group/13c5cdeba4326b6781e2f783c9fb988f]
arm group [clinicaltrials_vocabulary:arm-group]
NCT02099240 arm group 13c5cdeba4326b6781e2f783c9fb988f [clinicaltrials_resource:NCT02099240/arm-group/13c5cdeba4326b6781e2f783c9fb988f]
Bio2RDF identifier
NCT02099240/arm-group/13c5cdeba4326b6781e2f783c9fb988f
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... c5cdeba4326b6781e2f783c9fb988f
description [clinicaltrials_vocabulary:description]
intravenous antibiotic therapy plus early switch to oral antibiotic therapy
identifier
clinicaltrials_resource:NCT02099240/arm-group/13c5cdeba4326b6781e2f783c9fb988f
title
NCT02099240 arm group 13c5cdeba4326b6781e2f783c9fb988f
@en
type
label
NCT02099240 arm group 13c5cdeb ...... 5cdeba4326b6781e2f783c9fb988f]
@en